Value-based pricing of drugs with multiple indications or in combinations — lessons from Europe
Crossref DOI link: https://doi.org/10.1038/s41571-021-00561-6
Published Online: 2021-09-23
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vokinger, Kerstin N. http://orcid.org/0000-0002-6997-7384
Kesselheim, Aaron S.
Text and Data Mining valid from 2021-09-23
Version of Record valid from 2021-09-23
Article History
First Online: 23 September 2021
Competing interests
: The authors declare no competing interests.